News Releases

IRVINE, Calif., Sep 03, 2008 (BUSINESS WIRE) -- Endologix, Inc. (Nasdaq:ELGX) today announced that six-year patient follow-up data from the Company's Powerlink(R) System pivotal clinical trial supporting the durability of the Powerlink System as a minimally invasive treatment for abdominal aortic aneurysm (AAA) was published in the peer-reviewed Jo...

IRVINE, Calif., Jul 16, 2008 (BUSINESS WIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer of the Powerlink(R) System for the minimally invasive treatment of abdominal aortic aneurysms (AAA), announces the appointment of Joseph A. DeJohn as Vice President of Sales, effective immediately. Mr. DeJohn brings more than 20 years of sales management experi...

IRVINE, Calif., May 21, 2008 (BUSINESS WIRE) -- Endologix, Inc. (Nasdaq:ELGX) today announced that President and Chief Executive Officer John McDermott will make a presentation to the investment community at the Friedman Billings Ramsey 12th Annual Spring Investor Conference on Wednesday, May 28 at 2:15 p.m. Eastern time (11:15 a.m. Pacific time). ...

IRVINE, Calif., Apr 24, 2008 (BUSINESS WIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and manufacturer of the Powerlink(R) System endoluminal stent graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA), today announced financial results for the three months ended March 31, 2008. "We are reporting record total r...